Muzrif Munas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Muzrif Munas has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chathurika J. Kariyawasam
Ministry of Health
2 shared publications - Suraj Perera
Ministry of Health
2 shared publications - Carmen Koo
Environmental Health Institute, National Environment Agency, Singapore, Singapore
1 shared publication - Chamarika Jayanetti Weerasekera
Faculty of Medical Sciences, University of Sri Jayewardenepura Department of Parasitology Gangodawila, Nugegoda
1 shared publication - Deepika Fernando
Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
1 shared publication - Hapuarachchige Chanditha Hapuarachchi
Environmental Health Institute, National Environment Agency, Singapore 138667, Singapore
1 shared publication
Latest Publications
- Open Access
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 86
Oesophageal cancer in Sri Lanka: change of pattern over the past two decades
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 86
Open AccessOesophageal cancer in Sri Lanka: change of pattern over the past two decades
- Open Access
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 63
The surge of colorectal cancer in Sri Lanka
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 63
Open AccessThe surge of colorectal cancer in Sri Lanka
- Open Access
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 125
An insight into ovarian cancer incidence trends in Sri Lanka, 2005-2019
- 13 July 2022
- Published by Sri Lanka Journals Online in Journal of the College of Community Physicians of Sri Lanka
- Vol. 27 (5) , 125
Open AccessAn insight into ovarian cancer incidence trends in Sri Lanka, 2005-2019
- 3 March 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (3) , 964-967
Case Report: The First Case of Genotypically Confirmed Plasmodium falciparum Kelch 13 Propeller Mutation in Sri Lanka and Its Implications on the Elimination Status of Malaria
This case report discusses recrudescence of imported Plasmodium falciparum malaria, in the presence of P. falciparum Kelch13 (PfK13) propeller mutation, in a patient diagnosed and fully treated with artemether–lumefantrine under direct observation in Sri Lanka. This patient presented with a history of 5 days of fever following his arrival from the Democratic Republic of Congo (DRC). He had visited Rwanda 1 week before arrival to Sri Lanka. Treatment was commenced with artemisinin-based combination therapy, artemether–lumefantrine, which is the first-line drug recommended for uncomplicated falciparum malaria. Blood smears were negative for parasites by the third day of treatment. Approximately 2 weeks later, he developed fever again and was diagnosed as having a recrudescence of falciparum malaria. He was treated and responded to the second-line antimalarial dihydroartemisinin–piperaquine. Molecular testing of blood taken from the first infection revealed the presence of amino acid substitutions K189T and R561H within the PfK13 gene. R561H mutation is associated with delayed parasite clearance in Southeast Asia. Although seldom reported from DRC, an emergence and clonal expansion of parasites harboring R561H allele has been reported from Rwanda recently; thus, it is likely that this patient may have got the infection from Rwanda. Sri Lanka eliminated malaria in 2016. However, in the backdrop of continuing imported malaria cases, early diagnosis and prompt treatment is essential to prevent the re-establishment of the disease.
- 3 March 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (3) , 964-967
Case Report: The First Case of Genotypically Confirmed Plasmodium falciparum Kelch 13 Propeller Mutation in Sri Lanka and Its Implications on the Elimination Status of Malaria
This case report discusses recrudescence of imported Plasmodium falciparum malaria, in the presence of P. falciparum Kelch13 (PfK13) propeller mutation, in a patient diagnosed and fully treated with artemether–lumefantrine under direct observation in Sri Lanka. This patient presented with a history of 5 days of fever following his arrival from the Democratic Republic of Congo (DRC). He had visited Rwanda 1 week before arrival to Sri Lanka. Treatment was commenced with artemisinin-based combination therapy, artemether–lumefantrine, which is the first-line drug recommended for uncomplicated falciparum malaria. Blood smears were negative for parasites by the third day of treatment. Approximately 2 weeks later, he developed fever again and was diagnosed as having a recrudescence of falciparum malaria. He was treated and responded to the second-line antimalarial dihydroartemisinin–piperaquine. Molecular testing of blood taken from the first infection revealed the presence of amino acid substitutions K189T and R561H within the PfK13 gene. R561H mutation is associated with delayed parasite clearance in Southeast Asia. Although seldom reported from DRC, an emergence and clonal expansion of parasites harboring R561H allele has been reported from Rwanda recently; thus, it is likely that this patient may have got the infection from Rwanda. Sri Lanka eliminated malaria in 2016. However, in the backdrop of continuing imported malaria cases, early diagnosis and prompt treatment is essential to prevent the re-establishment of the disease.